Published in Neurology on April 09, 2008
The neuropathology of probable Alzheimer disease and mild cognitive impairment. Ann Neurol (2009) 4.96
Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention. Dialogues Clin Neurosci (2009) 2.86
Vascular risk factors and longitudinal changes on brain MRI: the ARIC study. Neurology (2011) 1.92
Insulin metabolism and the risk of Alzheimer disease: the Rotterdam Study. Neurology (2010) 1.64
Human cerebral neuropathology of Type 2 diabetes mellitus. Biochim Biophys Acta (2008) 1.46
Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease. J Neuropathol Exp Neurol (2009) 1.39
Cognitive impairment in diabetic patients: Can diabetic control prevent cognitive decline? J Diabetes Investig (2012) 1.30
Vascular risk factors: imaging and neuropathologic correlates. J Alzheimers Dis (2010) 1.22
Microglia activation and anti-inflammatory regulation in Alzheimer's disease. Mol Neurobiol (2010) 1.22
Metabolic syndrome, inflammation, and nonamnestic mild cognitive impairment in older persons: a population-based study. Alzheimer Dis Assoc Disord (2010) 1.09
Diabetes and risk of Parkinson's disease: a systematic review and meta-analysis. Diabetes Care (2011) 1.09
Modifiable Midlife Risk Factors for Late-Life Cognitive Impairment and Dementia. Curr Psychiatry Rev (2009) 1.09
Diabetes mellitus and risk of dementia: A meta-analysis of prospective observational studies. J Diabetes Investig (2013) 1.07
Insulin is differentially related to cognitive decline and atrophy in Alzheimer's disease and aging. Biochim Biophys Acta (2011) 1.03
Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain. Biochim Biophys Acta (2014) 1.01
Insulin reduces neuronal excitability by turning on GABA(A) channels that generate tonic current. PLoS One (2011) 0.98
Rosiglitazone and cognitive stability in older individuals with type 2 diabetes and mild cognitive impairment. Diabetes Care (2010) 0.98
Type 2 diabetes mellitus, dyslipidemia, and Alzheimer's disease. J Alzheimers Dis (2010) 0.93
IRS-2 Deficiency impairs NMDA receptor-dependent long-term potentiation. Cereb Cortex (2011) 0.87
Alzheimer's disease and type 2 diabetes: exploring the association to obesity and tyrosine hydroxylase. CNS Neurol Disord Drug Targets (2012) 0.85
Insulin: an emerging treatment for Alzheimer's disease dementia? Curr Neurol Neurosci Rep (2012) 0.84
The GLP-1 Receptor Agonist Liraglutide Improves Memory Function and Increases Hippocampal CA1 Neuronal Numbers in a Senescence-Accelerated Mouse Model of Alzheimer's Disease. J Alzheimers Dis (2015) 0.82
The association of diabetes and dementia and possible implications for nondiabetic populations. Expert Rev Neurother (2011) 0.82
The link between iron, metabolic syndrome, and Alzheimer's disease. J Neural Transm (Vienna) (2010) 0.82
Experimental induction of type 2 diabetes in aging-accelerated mice triggered Alzheimer-like pathology and memory deficits. J Alzheimers Dis (2014) 0.81
Soluble and cell-associated insulin receptor dysfunction correlates with severity of HAND in HIV-infected women. PLoS One (2012) 0.81
Effects of insulin resistance on white matter microstructure in middle-aged and older adults. Neurology (2014) 0.81
Altered gene expression profiles in the hippocampus and prefrontal cortex of type 2 diabetic rats. BMC Genomics (2012) 0.81
Co-location of HDAC2 and insulin signaling components in the adult mouse hippocampus. Cell Mol Neurobiol (2012) 0.80
Go to the head of the class to avoid vascular dementia and skip diabetes and obesity. Neurology (2008) 0.79
Diabetes Mellitus Induces Alzheimer's Disease Pathology: Histopathological Evidence from Animal Models. Int J Mol Sci (2016) 0.79
Insulin and sex interactions in older adults with mild cognitive impairment. J Alzheimers Dis (2012) 0.79
Can Ketones Help Rescue Brain Fuel Supply in Later Life? Implications for Cognitive Health during Aging and the Treatment of Alzheimer's Disease. Front Mol Neurosci (2016) 0.78
Parameters of glucose metabolism and the aging brain: a magnetization transfer imaging study of brain macro- and micro-structure in older adults without diabetes. Age (Dordr) (2015) 0.78
Insulin resistance: an emerging link in Alzheimer's disease. Neurol Sci (2013) 0.77
Glucose but not insulin or insulin resistance is associated with memory performance in middle-aged non-diabetic women: a cross sectional study. Diabetol Metab Syndr (2015) 0.77
[Diabetes and dementia]. Z Gerontol Geriatr (2012) 0.77
Circulating biomarkers that predict incident dementia. Alzheimers Res Ther (2014) 0.77
Apolipoprotein E Genotype and Sex Influence Glucose Tolerance in Older Adults: A Cross-Sectional Study. Dement Geriatr Cogn Dis Extra (2016) 0.76
Effects of exercise on brain functions in diabetic animal models. World J Diabetes (2015) 0.76
Pharmacological Treatment of Alzheimer's Disease: Is it Progressing Adequately? Open Neurol J (2009) 0.75
Diabetes care among elderly medicare beneficiaries with Parkinson's disease and diabetes. J Diabetes Metab Disord (2015) 0.75
A link between type 2 diabetes and brain function. JAAPA (2013) 0.75
Recent Progress in Alzheimer's Disease Research, Part 2: Genetics and Epidemiology. J Alzheimers Dis (2017) 0.75
TCF7L2 polymorphism and cognitive test performance in cardiovascular disease. Psychogeriatrics (2012) 0.75
Gut to Brain Dysbiosis: Mechanisms Linking Western Diet Consumption, the Microbiome, and Cognitive Impairment. Front Behav Neurosci (2017) 0.75
Metabolic Alterations Associated to Brain Dysfunction in Diabetes. Aging Dis (2015) 0.75
Healthy young hearts sharper older minds make. Ann Neurol (2013) 0.75
Treadmill exercise ameliorates Alzheimer disease-associated memory loss through the Wnt signaling pathway in the streptozotocin-induced diabetic rats. J Exerc Rehabil (2016) 0.75
Role of anti-diabetic drugs as therapeutic agents in Alzheimer's disease. EXCLI J (2015) 0.75
The diabetic brain and cognition. J Neural Transm (Vienna) (2017) 0.75
The Impact of Microbiota-Gut-Brain Axis on Diabetic Cognition Impairment. Front Aging Neurosci (2017) 0.75
Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature (1998) 15.24
The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation. Nat Neurosci (2001) 5.29
A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nat Genet (1992) 4.31
Current status of clinical islet transplantation. Transplantation (2005) 4.17
A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med (1989) 2.79
Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst (1996) 2.78
Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet (2002) 2.76
HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy. Nat Med (1998) 2.68
The Swedish mutation causes early-onset Alzheimer's disease by beta-secretase cleavage within the secretory pathway. Nat Med (1995) 2.44
Association between schizophrenia and homozygosity at the dopamine D3 receptor gene. J Med Genet (1992) 2.32
Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men. Hypertension (1998) 2.31
Diabetes, prediabetes and cancer mortality. Diabetologia (2010) 2.22
Cancer risk in patients with diabetes mellitus. Cancer Causes Control (1991) 2.18
Echocardiographic and electrocardiographic diagnoses of left ventricular hypertrophy predict mortality independently of each other in a population of elderly men. Circulation (2001) 2.10
New aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR). J Intern Med (2010) 2.09
Presenilin mutations associated with Alzheimer disease cause defective intracellular trafficking of beta-catenin, a component of the presenilin protein complex. Nat Med (1999) 2.03
Presenilin-1 mutations in Alzheimer's disease. Nature (2000) 1.97
Kidney function and discrimination of cardiovascular risk in middle-aged men. J Intern Med (2009) 1.97
Relative abundance of Alzheimer A beta amyloid peptide variants in Alzheimer disease and normal aging. Proc Natl Acad Sci U S A (1994) 1.91
Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients. Diabetologia (2008) 1.90
Physiological hyperglycemia slows gastric emptying in normal subjects and patients with insulin-dependent diabetes mellitus. Gastroenterology (1997) 1.77
Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function. J Clin Invest (1997) 1.74
Myocardial infarction and prevalence of diabetes mellitus. Is increased casual blood glucose at admission a reliable criterion for the diagnosis of diabetes? Eur Heart J (2001) 1.66
A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease. Ann Clin Biochem (2009) 1.66
Direct medical costs for patients with type 2 diabetes in Sweden. J Intern Med (2000) 1.63
Characterization of stable complexes involving apolipoprotein E and the amyloid beta peptide in Alzheimer's disease brain. Neuron (1995) 1.56
Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism (1990) 1.56
Changes in body mass index following newly diagnosed type 2 diabetes and risk of cardiovascular mortality: a cohort study of 8486 primary-care patients. Diabetes Metab (2013) 1.55
High prevalence of polycystic ovaries and associated clinical, endocrine, and metabolic features in women with previous gestational diabetes mellitus. J Clin Endocrinol Metab (1998) 1.51
Expression of carbonic anhydrase IX suggests poor outcome in rectal cancer. Br J Cancer (2009) 1.44
Sleep-disordered breathing and glucose metabolism in hypertensive men: a population-based study. J Intern Med (2001) 1.33
Excessive production of amyloid beta-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation. Proc Natl Acad Sci U S A (1994) 1.31
Changes in physical activity are associated with changes in metabolic cardiovascular risk factors. Diabetologia (2001) 1.31
Angiotensin II and the endocrine pancreas: effects on islet blood flow and insulin secretion in rats. Diabetologia (1998) 1.31
Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus. Kidney Int (1999) 1.31
Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrant. Hum Mol Genet (1996) 1.26
No difference in cerebral glucose metabolism in patients with Alzheimer disease and differing apolipoprotein E genotypes. Arch Neurol (1997) 1.25
The metabolism of lipids in mouse pancreatic islets. The biosynthesis of triacylglycerols and phospholipids. Biochem J (1975) 1.24
Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab (1995) 1.23
Alpha 1-antichymotrypsin regulates Alzheimer beta-amyloid peptide fibril formation. Proc Natl Acad Sci U S A (1995) 1.22
Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease. Mol Psychiatry (2012) 1.20
Glucose metabolism and the risk of Alzheimer's disease and dementia: a population-based 12 year follow-up study in 71-year-old men. Diabetologia (2009) 1.19
A population-based study of the prevalence of diabetes and impaired glucose tolerance in adults in northern Sudan. Diabetes Care (1996) 1.19
The metabolism of lipids in mouse pancreatic islets. The oxidation of fatty acids and ketone bodies. Biochem J (1975) 1.18
Insulin sensitivity, proinsulin and insulin as predictors of coronary heart disease. A population-based 10-year, follow-up study in 70-year old men using the euglycaemic insulin clamp. Diabetologia (2005) 1.15
Metabolic syndrome and risk for heart failure in middle-aged men. Heart (2006) 1.13
DNA polymorphisms within the porphobilinogen deaminase gene in two Swedish families with acute intermittent porphyria. Hum Genet (1988) 1.13
Predominant deposition of amyloid-beta 42(43) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene. Am J Pathol (1996) 1.12
Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables. Clin Endocrinol (Oxf) (1994) 1.12
Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance. J Clin Endocrinol Metab (1994) 1.11
Apolipoprotein E genotype determines survival in the oldest old (85 years or older) who have good cognition. Arch Neurol (1996) 1.11
Cerebrospinal fluid A beta42 is increased early in sporadic Alzheimer's disease and declines with disease progression. Ann Neurol (1999) 1.11
A serine to glycine substitution at position 9 in the extracellular N-terminal part of the dopamine D3 receptor protein: no role in the genetic predisposition to bipolar affective disorder. Psychiatry Res (1993) 1.10
Left ventricular concentric remodeling rather than left ventricular hypertrophy is related to the insulin resistance syndrome in elderly men. Circulation (2000) 1.09
Well-being and treatment satisfaction in adults with diabetes: a Swedish population-based study. Qual Life Res (1995) 1.09
Reduction of phosphorylated tau during memantine treatment of Alzheimer's disease. Dement Geriatr Cogn Disord (2007) 1.09
Variants of the TCF7L2 gene are associated with beta cell dysfunction and confer an increased risk of type 2 diabetes mellitus in the ULSAM cohort of Swedish elderly men. Diabetologia (2007) 1.09
Quantification of Alzheimer amyloid beta peptides ending at residues 40 and 42 by novel ELISA systems. Mol Med (2000) 1.09
An echolucent carotid artery intima-media complex is a new and independent predictor of mortality in an elderly male cohort. Atherosclerosis (2009) 1.08
Several factors associated with the insulin resistance syndrome are predictors of left ventricular systolic dysfunction in a male population after 20 years of follow-up. Am Heart J (2001) 1.08
EGFR gene copy number assessment from areas with highest EGFR expression predicts response to anti-EGFR therapy in colorectal cancer. Br J Cancer (2011) 1.06
Unique physicochemical profile of beta-amyloid peptide variant Abeta1-40E22G protofibrils: conceivable neuropathogen in arctic mutant carriers. J Mol Biol (2004) 1.06
On the turnover of brain cholesterol in patients with Alzheimer's disease. Abnormal induction of the cholesterol-catabolic enzyme CYP46 in glial cells. Neurosci Lett (2001) 1.05
Prevalence of insulin resistance in essential hypertension. J Hypertens (1995) 1.05
Sympathetic outflow in human muscle nerves increases during hypoglycemia. Diabetes (1986) 1.05
Pittsburgh compound-B and Alzheimer's disease biomarkers in CSF, plasma and urine: An exploratory study. Dement Geriatr Cogn Disord (2010) 1.04
Late-life obesity is associated with smaller global and regional gray matter volumes: a voxel-based morphometric study. Int J Obes (Lond) (2012) 1.04
Cognitive function and risk of stroke in elderly men. Neurology (2010) 1.04
Anti-insulin serum coupled to Sepharose 4B as a tool for the investigation of insulin biosynthesis in the B-cells of obese hyperglycemic mice. Endocrinology (1975) 1.04
Nicotinamide adenine dinucleotide phosphate-converting enzymes and adenosine triphosphate citrate lyase in some tissues and organs of New Zealand obese mice with special reference to the enzyme pattern of the pancreatic islets. J Histochem Cytochem (1975) 1.03
The role of APOE polymorphisms in late-onset dementias. Cell Mol Life Sci (1998) 1.03
The Glu318Gly mutation of the presenilin-1 gene does not necessarily cause Alzheimer's disease. Ann Neurol (1998) 1.03
Elevated ambulatory day-time blood pressure in women with polycystic ovary syndrome: a sign of a pre-hypertensive state? Hum Reprod (1996) 1.02
Postprandial changes in gut regulatory peptides in gastric bypass patients. Int J Obes (Lond) (2008) 1.02
Cytotoxic effects of streptozotocin and N-nitrosomethylurea on the pancreatic B cells with special regard to the role of nicotinamide-adenine dinucleotide. Biochem J (1974) 1.01
Application of prazosin is associated with an increase of insulin sensitivity in obese patients with hypertension. Diabetologia (1988) 1.01
Interaction between estrogen receptor 1 and the epsilon4 allele of apolipoprotein E increases the risk of familial Alzheimer's disease in women. Neurosci Lett (2000) 1.00
Serum cystatin C and the risk of Alzheimer disease in elderly men. Neurology (2008) 0.99
Alpha-ketoglutarate dehydrogenase in Alzheimer brains bearing the APP670/671 mutation. Ann Neurol (1998) 0.99
Systematic review with meta-analysis: associations between coeliac disease and type 1 diabetes. Aliment Pharmacol Ther (2014) 0.99
Time course of female-to-male sex reversal in 38,XX fetal and postnatal pigs. Dev Dyn (2001) 0.98
Clinic-based cases with frontotemporal dementia show increased cerebrospinal fluid tau and high apolipoprotein E epsilon4 frequency, but no tau gene mutations. Exp Neurol (2001) 0.97
Diazoxide treatment at onset preserves residual insulin secretion in adults with autoimmune diabetes. Diabetes (1996) 0.97